Latino Semaglutide Study

NCT05087342 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

119

Enrollment

OTHER

Sponsor class

Conditions

Obesity
Obesity; Drug
Overweight or Obesity
Weight Loss
Weight Loss Trajectory
Weight, Body

Interventions

DRUG: Semaglutide 2.4mg
DRUG: Placebo

Sponsor

Loma Linda University

Collaborators

[object Object]